APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phenobarbital

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Phenobarbital Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry ResearchPhenobarbital Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Phenobarbital Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Phenobarbital Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phenobarbital Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Phenobarbital Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Phenobarbital market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Phenobarbital is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phenobarbital is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phenobarbital is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Phenobarbital market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Phenobarbital market include Xinyi, Spectrum Chemical Mfg. Corp., Mil-Spec Industries, Mallinckrodt, Inc., Ganes Chemicals, Inc. and Alfa Chemical Corp., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Phenobarbital market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phenobarbital and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phenobarbital sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Phenobarbital market size, projected growth trends, production technologies, key applications, and end-use industries.

Phenobarbital Segment by Company

Xinyi

Spectrum Chemical Mfg. Corp.

Mil-Spec Industries

Mallinckrodt, Inc.

Ganes Chemicals, Inc.

Alfa Chemical Corp.

Phenobarbital Segment by Type

Human use

For Livestock

Phenobarbital Segment by Application

Sleeping Pill

Tranquilizer

Phenobarbital Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Phenobarbital status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Phenobarbital market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Phenobarbital significant trends, drivers, influence factors in global and regions.

6. To analyze Phenobarbital competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenobarbital market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phenobarbital and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenobarbital.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Phenobarbital market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phenobarbital industry.

Chapter 3: Detailed analysis of Phenobarbital manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Phenobarbital in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Phenobarbital in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Phenobarbital Industry Trends Table 2. Phenobarbital Industry Drivers Table 3. Phenobarbital Industry Opportunities and Challenges Table 4. Phenobarbital Industry Restraints Table 5. Global Phenobarbital Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Phenobarbital Revenue Share by Company (2021-2026) Table 7. Global Phenobarbital Sales Volume by Company (k units) & (2021-2026) Table 8. Global Phenobarbital Sales Volume Share by Company (2021-2026) Table 9. Global Phenobarbital Average Price (US$/unit) of Company (2021-2026) Table 10. Global Phenobarbital Company Ranking, (2024-2026) & (USD Million) Table 11. Global Phenobarbital Key Company Manufacturing Base & Headquarters Table 12. Global Phenobarbital Company, Product Type & Application Table 13. Global Phenobarbital Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Phenobarbital by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Human use Table 18. Significant Companies of For Livestock Table 19. Global Phenobarbital Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Phenobarbital Sales Volume by Type (2021-2026) & (k units) Table 21. Global Phenobarbital Sales Volume by Type (2027-2032) & (k units) Table 22. Global Phenobarbital Sales Volume Share by Type (2021-2026) Table 23. Global Phenobarbital Sales Volume Share by Type (2027-2032) Table 24. Global Phenobarbital Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Phenobarbital Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Phenobarbital Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Phenobarbital Sales Value Share by Type (2021-2026) Table 28. Global Phenobarbital Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Sleeping Pill Table 30. Significant Companies of Tranquilizer Table 31. Global Phenobarbital Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Phenobarbital Sales Volume by Application (2021-2026) & (k units) Table 33. Global Phenobarbital Sales Volume by Application (2027-2032) & (k units) Table 34. Global Phenobarbital Sales Volume Share by Application (2021-2026) Table 35. Global Phenobarbital Sales Volume Share by Application (2027-2032) Table 36. Global Phenobarbital Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Phenobarbital Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Phenobarbital Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Phenobarbital Sales Value Share by Application (2021-2026) Table 40. Global Phenobarbital Sales Value Share by Application (2027-2032) Table 41. Global Phenobarbital Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Phenobarbital Sales by Region (2021-2026) & (k units) Table 43. Global Phenobarbital Sales Market Share by Region (2021-2026) Table 44. Global Phenobarbital Sales by Region (2027-2032) & (k units) Table 45. Global Phenobarbital Sales Market Share by Region (2027-2032) Table 46. Global Phenobarbital Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Phenobarbital Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Phenobarbital Sales Value Share by Region (2021-2026) Table 49. Global Phenobarbital Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Phenobarbital Sales Value Share by Region (2027-2032) Table 51. Global Phenobarbital Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Phenobarbital Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Phenobarbital Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Phenobarbital Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Phenobarbital Sales by Country (2021-2026) & (k units) Table 56. Global Phenobarbital Sales Market Share by Country (2021-2026) Table 57. Global Phenobarbital Sales by Country (2027-2032) & (k units) Table 58. Global Phenobarbital Sales Market Share by Country (2027-2032) Table 59. Global Phenobarbital Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Phenobarbital Sales Value Market Share by Country (2021-2026) Table 61. Global Phenobarbital Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Phenobarbital Sales Value Market Share by Country (2027-2032) Table 63. Xinyi Company Information Table 64. Xinyi Business Overview Table 65. Xinyi Phenobarbital Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Xinyi Phenobarbital Product Portfolio Table 67. Xinyi Recent Development Table 68. Spectrum Chemical Mfg. Corp. Company Information Table 69. Spectrum Chemical Mfg. Corp. Business Overview Table 70. Spectrum Chemical Mfg. Corp. Phenobarbital Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Spectrum Chemical Mfg. Corp. Phenobarbital Product Portfolio Table 72. Spectrum Chemical Mfg. Corp. Recent Development Table 73. Mil-Spec Industries Company Information Table 74. Mil-Spec Industries Business Overview Table 75. Mil-Spec Industries Phenobarbital Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Mil-Spec Industries Phenobarbital Product Portfolio Table 77. Mil-Spec Industries Recent Development Table 78. Mallinckrodt, Inc. Company Information Table 79. Mallinckrodt, Inc. Business Overview Table 80. Mallinckrodt, Inc. Phenobarbital Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Mallinckrodt, Inc. Phenobarbital Product Portfolio Table 82. Mallinckrodt, Inc. Recent Development Table 83. Ganes Chemicals, Inc. Company Information Table 84. Ganes Chemicals, Inc. Business Overview Table 85. Ganes Chemicals, Inc. Phenobarbital Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Ganes Chemicals, Inc. Phenobarbital Product Portfolio Table 87. Ganes Chemicals, Inc. Recent Development Table 88. Alfa Chemical Corp. Company Information Table 89. Alfa Chemical Corp. Business Overview Table 90. Alfa Chemical Corp. Phenobarbital Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Alfa Chemical Corp. Phenobarbital Product Portfolio Table 92. Alfa Chemical Corp. Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Phenobarbital Distributors List Table 96. Phenobarbital Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Phenobarbital Product Image Figure 2. Global Phenobarbital Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phenobarbital Sales Value (2021-2032) & (US$ Million) Figure 4. Global Phenobarbital Sales (2021-2032) & (k units) Figure 5. Global Phenobarbital Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Phenobarbital Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Human use Image Figure 10. For Livestock Image Figure 11. Global Phenobarbital Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Phenobarbital Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Phenobarbital Sales Volume Share by Type (2021-2032) Figure 14. Global Phenobarbital Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Phenobarbital Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Phenobarbital Sales Value Share by Type (2021-2032) Figure 17. Sleeping Pill Image Figure 18. Tranquilizer Image Figure 19. Global Phenobarbital Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Phenobarbital Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Phenobarbital Sales Volume Share by Application (2021-2032) Figure 22. Global Phenobarbital Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Phenobarbital Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Phenobarbital Sales Value Share by Application (2021-2032) Figure 25. Global Phenobarbital Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Phenobarbital Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Phenobarbital Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Phenobarbital Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Phenobarbital Sales Value (2021-2032) & (US$ Million) Figure 30. North America Phenobarbital Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Phenobarbital Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Phenobarbital Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Phenobarbital Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Phenobarbital Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Phenobarbital Sales Value (2021-2032) & (US$ Million) Figure 36. South America Phenobarbital Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Phenobarbital Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Phenobarbital Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Phenobarbital Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Phenobarbital Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Phenobarbital Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Phenobarbital Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Phenobarbital Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Human use
  • For Livestock
Applications
  • Sleeping Pill
  • Tranquilizer
Companies covered
  • Xinyi
  • Spectrum Chemical Mfg. Corp.
  • Mil-Spec Industries
  • Mallinckrodt, Inc.
  • Ganes Chemicals, Inc.
  • Alfa Chemical Corp.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phenobarbital Sales Value (2021-2032)
  4. 1.2.2 Global Phenobarbital Sales Volume (2021-2032)
  5. 1.2.3 Global Phenobarbital Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Phenobarbital Market Dynamics
  1. 2.1 Phenobarbital Industry Trends
  2. 2.2 Phenobarbital Industry Drivers
  3. 2.3 Phenobarbital Industry Opportunities and Challenges
  4. 2.4 Phenobarbital Industry Restraints
3 Phenobarbital Market by Company
  1. 3.1 Global Phenobarbital Company Revenue Ranking in 2025
  2. 3.2 Global Phenobarbital Revenue by Company (2021-2026)
  3. 3.3 Global Phenobarbital Sales Volume by Company (2021-2026)
  4. 3.4 Global Phenobarbital Average Price by Company (2021-2026)
  5. 3.5 Global Phenobarbital Company Ranking (2024-2026)
  6. 3.6 Global Phenobarbital Company Manufacturing Base and Headquarters
  7. 3.7 Global Phenobarbital Company Product Type and Application
  8. 3.8 Global Phenobarbital Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Phenobarbital Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Phenobarbital Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Phenobarbital Market by Type
  1. 4.1 Phenobarbital Type Introduction
  2. 4.1.1 Human use
  3. 4.1.2 For Livestock
  4. 4.2 Global Phenobarbital Sales Volume by Type
  5. 4.2.1 Global Phenobarbital Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Phenobarbital Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Phenobarbital Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Phenobarbital Sales Value by Type
  9. 4.3.1 Global Phenobarbital Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Phenobarbital Sales Value by Type (2021-2032)
  11. 4.3.3 Global Phenobarbital Sales Value Share by Type (2021-2032)
5 Phenobarbital Market by Application
  1. 5.1 Phenobarbital Application Introduction
  2. 5.1.1 Sleeping Pill
  3. 5.1.2 Tranquilizer
  4. 5.2 Global Phenobarbital Sales Volume by Application
  5. 5.2.1 Global Phenobarbital Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Phenobarbital Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Phenobarbital Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Phenobarbital Sales Value by Application
  9. 5.3.1 Global Phenobarbital Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Phenobarbital Sales Value by Application (2021-2032)
  11. 5.3.3 Global Phenobarbital Sales Value Share by Application (2021-2032)
6 Phenobarbital Regional Sales and Value Analysis
  1. 6.1 Global Phenobarbital Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phenobarbital Sales by Region (2021-2032)
  3. 6.2.1 Global Phenobarbital Sales by Region: 2021-2026
  4. 6.2.2 Global Phenobarbital Sales by Region (2027-2032)
  5. 6.3 Global Phenobarbital Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Phenobarbital Sales Value by Region (2021-2032)
  7. 6.4.1 Global Phenobarbital Sales Value by Region: 2021-2026
  8. 6.4.2 Global Phenobarbital Sales Value by Region (2027-2032)
  9. 6.5 Global Phenobarbital Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Phenobarbital Sales Value (2021-2032)
  12. 6.6.2 North America Phenobarbital Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Phenobarbital Sales Value (2021-2032)
  15. 6.7.2 Europe Phenobarbital Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Phenobarbital Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Phenobarbital Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Phenobarbital Sales Value (2021-2032)
  21. 6.9.2 South America Phenobarbital Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Phenobarbital Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Phenobarbital Sales Value Share by Country, 2025 VS 2032
7 Phenobarbital Country-level Sales and Value Analysis
  1. 7.1 Global Phenobarbital Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Phenobarbital Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Phenobarbital Sales by Country (2021-2032)
  4. 7.3.1 Global Phenobarbital Sales by Country (2021-2026)
  5. 7.3.2 Global Phenobarbital Sales by Country (2027-2032)
  6. 7.4 Global Phenobarbital Sales Value by Country (2021-2032)
  7. 7.4.1 Global Phenobarbital Sales Value by Country (2021-2026)
  8. 7.4.2 Global Phenobarbital Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Phenobarbital Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Phenobarbital Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Phenobarbital Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Phenobarbital Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Phenobarbital Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Phenobarbital Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Phenobarbital Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Phenobarbital Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Phenobarbital Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Phenobarbital Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Phenobarbital Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Phenobarbital Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Phenobarbital Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Phenobarbital Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Phenobarbital Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Phenobarbital Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Phenobarbital Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Phenobarbital Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Phenobarbital Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Phenobarbital Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Phenobarbital Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Phenobarbital Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Phenobarbital Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Phenobarbital Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Phenobarbital Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Phenobarbital Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Phenobarbital Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Phenobarbital Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Phenobarbital Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Phenobarbital Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Phenobarbital Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Phenobarbital Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Phenobarbital Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Phenobarbital Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Phenobarbital Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Phenobarbital Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Phenobarbital Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Phenobarbital Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Phenobarbital Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Phenobarbital Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Phenobarbital Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Phenobarbital Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Phenobarbital Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Phenobarbital Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Phenobarbital Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Phenobarbital Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Phenobarbital Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Phenobarbital Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Phenobarbital Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Phenobarbital Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Phenobarbital Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Phenobarbital Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Phenobarbital Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Phenobarbital Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Phenobarbital Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Phenobarbital Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Phenobarbital Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Phenobarbital Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Phenobarbital Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Phenobarbital Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Phenobarbital Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Phenobarbital Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Phenobarbital Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Phenobarbital Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Phenobarbital Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Phenobarbital Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Phenobarbital Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Phenobarbital Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Phenobarbital Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Phenobarbital Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Phenobarbital Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Phenobarbital Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Phenobarbital Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Phenobarbital Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Phenobarbital Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Phenobarbital Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Phenobarbital Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Phenobarbital Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Phenobarbital Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Phenobarbital Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Phenobarbital Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Phenobarbital Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Phenobarbital Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Phenobarbital Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xinyi
  2. 8.1.1 Xinyi Company Information
  3. 8.1.2 Xinyi Business Overview
  4. 8.1.3 Xinyi Phenobarbital Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xinyi Phenobarbital Product Portfolio
  6. 8.1.5 Xinyi Recent Developments
  7. 8.2 Spectrum Chemical Mfg. Corp.
  8. 8.2.1 Spectrum Chemical Mfg. Corp. Company Information
  9. 8.2.2 Spectrum Chemical Mfg. Corp. Business Overview
  10. 8.2.3 Spectrum Chemical Mfg. Corp. Phenobarbital Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Spectrum Chemical Mfg. Corp. Phenobarbital Product Portfolio
  12. 8.2.5 Spectrum Chemical Mfg. Corp. Recent Developments
  13. 8.3 Mil-Spec Industries
  14. 8.3.1 Mil-Spec Industries Company Information
  15. 8.3.2 Mil-Spec Industries Business Overview
  16. 8.3.3 Mil-Spec Industries Phenobarbital Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mil-Spec Industries Phenobarbital Product Portfolio
  18. 8.3.5 Mil-Spec Industries Recent Developments
  19. 8.4 Mallinckrodt, Inc.
  20. 8.4.1 Mallinckrodt, Inc. Company Information
  21. 8.4.2 Mallinckrodt, Inc. Business Overview
  22. 8.4.3 Mallinckrodt, Inc. Phenobarbital Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mallinckrodt, Inc. Phenobarbital Product Portfolio
  24. 8.4.5 Mallinckrodt, Inc. Recent Developments
  25. 8.5 Ganes Chemicals, Inc.
  26. 8.5.1 Ganes Chemicals, Inc. Company Information
  27. 8.5.2 Ganes Chemicals, Inc. Business Overview
  28. 8.5.3 Ganes Chemicals, Inc. Phenobarbital Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ganes Chemicals, Inc. Phenobarbital Product Portfolio
  30. 8.5.5 Ganes Chemicals, Inc. Recent Developments
  31. 8.6 Alfa Chemical Corp.
  32. 8.6.1 Alfa Chemical Corp. Company Information
  33. 8.6.2 Alfa Chemical Corp. Business Overview
  34. 8.6.3 Alfa Chemical Corp. Phenobarbital Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Alfa Chemical Corp. Phenobarbital Product Portfolio
  36. 8.6.5 Alfa Chemical Corp. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Phenobarbital Value Chain Analysis
  2. 9.1.1 Phenobarbital Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Phenobarbital Sales Mode & Process
  6. 9.2 Phenobarbital Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Phenobarbital Distributors
  9. 9.2.3 Phenobarbital Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst